Murali Neelakantan, who had left Indian pharma giant Cipla as global general counsel in 2015, has re-entered the in-house and pharmaceuticals space with Glenmark Pharmaceuticals after two years focusing on several legal education-related interests.

Cipla global general counsel (GC) and former Khaitan & Co partner Murali Neelakantan, has resigned in order to focus on a variety of policy, education and other projects, while also set to become an independent director of a former long-standing client.

Khaitan & Co Mumbai partner Murali Neelakantan has joined Indian pharmaceutical giant Cipla as its global general counsel (GC).